Stock IPCALAB IPCA LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Ipca Laboratories Limited

Equities

IPCALAB

INE571A01038

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 05:13:48 10/05/2024 pm IST 		5-day change 1st Jan Change
1,313 INR +2.23% Intraday chart for Ipca Laboratories Limited -1.85% +17.95%
29/03 Ipca Laboratories Limited Announces Cessation of Anand T. Kusre as an Independent Director CI
29/03 Ipca Laboratories Limited Appoints Swati Arvind Patankar as an Independent Director CI

Business Summary

Ipca Laboratories Limited is an India-based pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Number of employees: 16,167

Sales per Business

INR in Million2022Weight2023Weight Delta
Branded Generics
53.8 %
30,028 51.5 % 33,597 53.8 % +11.88%
Active Pharmaceutical Ingredients
24.4 %
15,132 26.0 % 15,217 24.4 % +0.56%
Generics
21.2 %
12,504 21.4 % 13,255 21.2 % +6.00%
Miscellaneous
0.5 %
300 0.5 % 298 0.5 % -0.57%
Export Incentives
0.1 %
302 0.5 % 59 0.1 % -80.34%
Sundry Balances Written Back
0.0 %
32 0.1 % 17 0.0 % -46.06%

Sales per region

INR in Million2022Weight2023Weight Delta
India
52.3 %
30,112 51.7 % 32,655 52.3 % +8.44%
Americas
10.2 %
6,707 11.5 % 6,367 10.2 % -5.07%
Europe
9.3 %
5,439 9.3 % 5,783 9.3 % +6.32%
Asia (excluding India)
7.8 %
4,615 7.9 % 4,885 7.8 % +5.84%
Africa
7.6 %
4,754 8.2 % 4,769 7.6 % +0.31%
United Kingdom
4.8 %
2,597 4.5 % 2,998 4.8 % +15.44%
Australasia
4.4 %
2,476 4.2 % 2,777 4.4 % +12.17%
Commonwealth of Independent States
3.5 %
1,598 2.7 % 2,210 3.5 % +38.29%

Managers

Managers TitleAgeSince
Ajitkumar Bhanwarlal Jain CEO
 Chief Executive Officer 68 02/80/02
Pranay Godha CEO
 Chief Executive Officer 51 16/03/16
Premchand Gigalal Godha CHM
 Chairman 77 31/75/31
Hitesh Kumar Maheshwari CTO
 Chief Tech/Sci/R&D Officer 50 16/23/16
Pabitra Kumar Bhattacharya CIO
 Chief Investment Officer - -
Ashok Kumar CTO
 Chief Tech/Sci/R&D Officer 70 06/00/06
Anil Pareek CTO
 Chief Tech/Sci/R&D Officer 67 11/00/11
Harish Pandurang Kamath CMP
 Compliance Officer 64 20/93/20
Sanjay Kapadia PRN
 Corporate Officer/Principal - -
Pabitrakumar Kalipada Bhattacharyya PRN
 Corporate Officer/Principal 55 -

Members of the board

Members of the board TitleAgeSince
Premchand Gigalal Godha CHM
 Chairman 77 31/75/31
Prashant Premchand Godha BRD
 Director/Board Member 76 16/11/16
Pranay Godha CEO
 Chief Executive Officer 51 16/03/16
Ajitkumar Bhanwarlal Jain CEO
 Chief Executive Officer 68 02/80/02
Manisha Premnath BRD
 Director/Board Member 50 21/14/21
Narendra Mairpady BRD
 Director/Board Member 69 20/22/20
Kamal Kishore Seth BRD
 Director/Board Member 78 29/19/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 253,700,000 132,593,199 ( 52.26 %) 0 52.26 %

Shareholders

NameEquities%Valuation
Kaygee Investments Pvt Ltd.
21.47 %
54,478,390 21.47 % 809 M ₹
HDFC Asset Management Co. Ltd. (Invt Mgmt)
8.504 %
21,575,116 8.504 % 320 M ₹
DSP Asset Managers Pvt. Ltd.
6.965 %
17,670,248 6.965 % 262 M ₹
Kaygee Laboratories Pvt Ltd.
6.610 %
16,770,000 6.610 % 249 M ₹
Chandurkar Investments Pvt Ltd.
5.501 %
13,956,010 5.501 % 207 M ₹
Kotak Mahindra Asset Management Co. Ltd.
4.457 %
11,307,470 4.457 % 168 M ₹
Paschim Chemicals Pvt Ltd.
3.996 %
10,138,000 3.996 % 151 M ₹
Usha M Chandurkar
3.272 %
8,302,000 3.272 % 123 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
2.778 %
7,048,848 2.778 % 105 M ₹
Premchand Gigalal Godha
2.292 %
5,814,680 2.292 % 86 M ₹

Holdings

NameEquities%Valuation
UNICHEM LABORATORIES LIMITED
52.67%
 37,081,011 52.67% 217,188,673 $
LYKA LABS LIMITED
36.34%
 12,024,923 36.34% 15,275,861 $

Company contact information

Ipca Laboratories Ltd.

125, Kandivli Industrial Estate Kandivili West

400067, Mumbai

+91 22 6647 4444

http://www.ipca.com
address Ipca Laboratories Limited(IPCALAB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Ipca Laboratories Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
1,313 INR
Average target price
1,163 INR
Spread / Average Target
-11.41%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IPCA LABORATORIES LIMITED Stock Ipca Laboratories Limited
+17.95% 3.99B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IPCALAB Stock
  4. Company Ipca Laboratories Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW